These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

700 related items for PubMed ID: 15230851

  • 1. Occult hepatitis B viral DNA in liver carcinomas from a region with a low prevalence of chronic hepatitis B infection.
    Kannangai R, Molmenti E, Arrazola L, Klein A, Choti M, Thomas DL, Torbenson M.
    J Viral Hepat; 2004 Jul; 11(4):297-301. PubMed ID: 15230851
    [Abstract] [Full Text] [Related]

  • 2. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
    Momosaki S, Nakashima Y, Kojiro M, Tabor E.
    J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
    [Abstract] [Full Text] [Related]

  • 3. Prevalence of occult hepatitis B virus infection among hepatopathy patients and healthy people in China.
    Fang Y, Shang QL, Liu JY, Li D, Xu WZ, Teng X, Zhao HW, Fu LJ, Zhang FM, Gu HX.
    J Infect; 2009 May; 58(5):383-8. PubMed ID: 19329189
    [Abstract] [Full Text] [Related]

  • 4. Hepatitis B virus DNA in liver tissue and risk for hepatocarcinogenesis in patients with hepatitis C virus-related chronic liver disease. A prospective study.
    Obika M, Shinji T, Fujioka S, Terada R, Ryuko H, Lwin AA, Shiraha H, Koide N.
    Intervirology; 2008 May; 51(1):59-68. PubMed ID: 18349544
    [Abstract] [Full Text] [Related]

  • 5. Quantification of hepatitis B virus covalently closed circular DNA in patients with hepatocellular carcinoma.
    Wong DK, Yuen MF, Poon RT, Yuen JC, Fung J, Lai CL.
    J Hepatol; 2006 Oct; 45(4):553-9. PubMed ID: 16904225
    [Abstract] [Full Text] [Related]

  • 6. Prevalence of low-level hepatitis B viremia in patients with HBV surface antigen-negative hepatocellular carcinoma with and without hepatitis C virus infection in Japan: analysis by COBAS TaqMan real-time PCR.
    Toyoda H, Kumada T, Kiriyama S, Sone Y, Tanikawa M, Hisanaga Y, Kanamori A.
    Intervirology; 2007 Oct; 50(4):241-4. PubMed ID: 17446712
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Molecular and serological aspects of HBsAg-negative hepatitis B virus infections in North America.
    Hsia CC, Scudamore CH, Di Bisceglie AM, Tabor E.
    J Med Virol; 2003 May; 70(1):20-6. PubMed ID: 12629639
    [Abstract] [Full Text] [Related]

  • 11. Preponderance of hepatitis B virus genotype B contributes to a better prognosis of chronic HBV infection in Okinawa, Japan.
    Sakugawa H, Nakasone H, Nakayoshi T, Orito E, Mizokami M, Yamashiro T, Maeshiro T, Kinjo F, Saito A, Miyagi Y.
    J Med Virol; 2002 Aug; 67(4):484-9. PubMed ID: 12115993
    [Abstract] [Full Text] [Related]

  • 12. Real-time quantitation of hepatitis B virus (HBV) DNA in tumorous and surrounding tissue from patients with hepatocellular carcinoma.
    Zanella I, Rossini A, Domenighini D, Albertini A, Cariani E.
    J Med Virol; 2002 Dec; 68(4):494-9. PubMed ID: 12376956
    [Abstract] [Full Text] [Related]

  • 13. Hepatitis B virus mutations associated with in situ expression of hepatitis B core antigen, viral load and prognosis in chronic hepatitis B patients.
    Zhu R, Zhang HP, Yu H, Li H, Ling YQ, Hu XQ, Zhu HG.
    Pathol Res Pract; 2008 Dec; 204(10):731-42. PubMed ID: 18597951
    [Abstract] [Full Text] [Related]

  • 14. The characteristics of the cell-mediated immune response identify different profiles of occult hepatitis B virus infection.
    Zerbini A, Pilli M, Boni C, Fisicaro P, Penna A, Di Vincenzo P, Giuberti T, Orlandini A, Raffa G, Pollicino T, Raimondo G, Ferrari C, Missale G.
    Gastroenterology; 2008 May; 134(5):1470-81. PubMed ID: 18355815
    [Abstract] [Full Text] [Related]

  • 15. Virological significance of low-level hepatitis B virus infection in patients with hepatitis C virus associated liver disease.
    Tanaka T, Inoue K, Hayashi Y, Abe A, Tsukiyama-Kohara K, Nuriya H, Aoki Y, Kawaguchi R, Kubota K, Yoshiba M, Koike M, Tanaka S, Kohara M.
    J Med Virol; 2004 Feb; 72(2):223-9. PubMed ID: 14695663
    [Abstract] [Full Text] [Related]

  • 16. [Chronic hepatitis B virus infection and the methylation status of p16INK4A promoter].
    Zhu R, Li BZ, Ling YQ, Zhang HP, Li H, Liu Y, Hu XQ, Zhu HG.
    Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):166-70. PubMed ID: 17649629
    [Abstract] [Full Text] [Related]

  • 17. Virological and clinical implication of core promoter C1752/V1753 and T1764/G1766 mutations in hepatitis B virus genotype D infection in Mongolia.
    Elkady A, Tanaka Y, Kurbanov F, Oynsuren T, Mizokami M.
    J Gastroenterol Hepatol; 2008 Mar; 23(3):474-81. PubMed ID: 18318825
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients.
    Squadrito G, Pollicino T, Cacciola I, Caccamo G, Villari D, La Masa T, Restuccia T, Cucinotta E, Scisca C, Magazzu D, Raimondo G.
    Cancer; 2006 Mar 15; 106(6):1326-30. PubMed ID: 16453330
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.